Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Q: Paragraph: McLaren Flint Hospital on Friday requested an administrative hearing before the state enforces the terms of an order over issues with the bacteria that causes Legionnaires' disease. The Flint Journal reports McLaren's attorneys say the order issued Wednesday by the Michigan Department of Health and Human Services and Department of Licensing and Regulatory Affairs contains allegations, findings and conclusions that are untrue. Flint, while under state financial management, switched to the Flint River for water in 2014 without treating it to reduce corrosion. Lead leached from pipes, contaminating the system. At the same time, a deadly Legionnaires' disease outbreak occurred that led to criminal charges against government officials. ___ Information from: The Flint Journal, http://www.mlive.com/flint Claim: Flint hospital wants hearing on order over Legionella risks.

A: A Flint hospital ordered by the state to take steps to reduce the risk of exposure to Legionella bacteria wants a hearing on the matter.
****
Q: Paragraph: A nurse extracts a vaccine in a file photo. Federal health officials said on Thursday the government has not conceded that vaccines cause autism even after a Georgia girl won federal compensation in a case arguing a vaccine led to her brain damage. REUTERS/Phil Klein Hannah Poling, 9, had a rare mitochondrial disorder and a federal court ruling said regular childhood vaccinations may have contributed to some of her autism-like symptoms. She was awarded compensation under the National Vaccine Injury Compensation Program in a case that became public this week. Some activists who argue vaccines can trigger autism jumped on the case as vindication of their cause. But Dr. Julie Gerberding, director of the U.S. Centers for Disease Control and Prevention, denied this. "Let me be very clear that (the) government has made absolutely no statement about indicating that vaccines are a cause of autism," Gerberding told reporters in a telephone briefing. "That is a complete mischaracterization of the findings of the case, and a complete mischaracterization of any of the science that we have at our disposal today. So I think we need to set the record straight on that." The vaccine injury program is a no-fault system that has a $2.5 billion fund built up from a 75-cent-per-dose tax on vaccines. It was set up to ensure companies would not be afraid to make vaccines, and to provide injured children an easier way to seek compensation. Thousands of lawsuits have been filed by parents who argue their children have autism caused by vaccines. The Institute of Medicine, an independent organization set up to inform U.S. policy, has found there is no evidence that vaccines can cause autism. Many recent studies have come to the same conclusion. Some autism advocacy groups argue that a mercury-containing preservative in vaccines called thimerosal can cause autism. Republican presidential candidate Sen. John McCain entered the debate last week, saying there is "strong evidence" linking autism to a thimerosal. Dr. Edwin Trevathan, director of the CDC's National Center on Birth Defects and Developmental Disabilities, said the Poling case did not demonstrate any link between vaccines and autism. "I think it's also worth noting that most children with autism do not seem to have a mitochondrial problem," he told the briefing. "So this association between mitochondrial disorders and autism is actually probably relatively rare. But the association between mitochondrial disorders and severe brain damage and dysfunction is one that is not as rare and is actually quite important." Trevathan said it is not clear whether a fever caused by a vaccine might further stress a child with such a condition, causing autism-like symptoms. Autism can have relatively mild symptoms or can severely disable a child by interfering with speech and behavior. No one knows what causes it. The CDC estimates that about one in every 150 children has autism or a related disorder such as Asperger's syndrome 560,000 people up to age 21 in the United States. "Our message to parents is that immunization is life-saving. There's absolutely nothing changed in the adamant recommendations that we are making to get children vaccinated," Gerberding said. Claim: Still no autism-vaccine link, say health officials.

A: Federal health officials said on Thursday the government has not conceded that vaccines cause autism even after a Georgia girl won federal compensation in a case arguing a vaccine led to her brain damage.
****
Q: Paragraph: Shares of Ariad Pharmaceuticals Inc, which makes the drug, Iclusig, rose as much as 40 percent after news that the U.S. Food and Drug Administration approved the more restricted use of on Friday. Iclusig was approved a year ago to treat chronic myeloid leukemia and Philadelphia chromosome positive acute lymphoblastic leukemia in patients who had failed to respond to at least one other therapy. It was suspended on October 31 after being associated with a higher-than-expected risk of life-threatening blood clots and narrowing of blood vessels. The FDA said it approved a revised label for the drug, limiting its use to patients with a specific genetic mutation and to those who are unable to use alternative treatments such as Novartis AG's Gleevec or Bristol Myers Squibb Co's Sprycel. The drug's label will note that vascular blockages, which have the potential to cause heart attacks, strokes and death, have occurred in at least 27 percent of patients treated with Iclusig. It will also warn of an increased risk of heart failure. "While this new restricted label will clearly cap Iclusig's sales potential, we still believe it can be a meaningful drug," Cory Kasimov, an analyst at J.P. Morgan, said in a research note. "The key question will now be whether Iclusig will be relegated to last line of defense (resulting in more modest sales potential) or will it begin to creep up the treatment algorithm." Doctors are allowed to prescribe drugs on an "off-label" basis for indications other than those approved by the FDA, though companies are not allowed to market them for such unapproved uses. Ariad said it will start selling the drug, its only approved product, from mid-January. Ariad's chief executive, Harvey Berger, told analysts on a conference call that about 1,300 patients a year will be eligible for Iclusig under the new label, down from 2,500 previously. The drug is expected to generate sales of $315 million by 2019 according to the average estimate of three analysts polled by Thomson Reuters. Iclusig costs at least $115,000 a year. The FDA is requiring the company to implement a risk management program to promote awareness of the risks associated with Iclusig. The company must also conduct additional trials to test different, potentially less toxic, doses of the drug. Dr. Richard Pazdur, head of the FDA's cancer division, said in an interview that if a less toxic dose was to be identified, "it would be reasonable," though speculative at this stage, to test Iclusig to another therapy for potential use in a broader patient population. Ariad's Berger said he expects the company to begin the dosing trial in the second half of 2014. "We believe these requirements are straightforward and manageable," he said. Ariad's shares rose 24 percent to $6.85 in afternoon trading on Nasdaq. Earlier they rose as high as $7.75. Claim: Ariad to resume sales of cancer drug Iclusig, shares jump.

A:
A leukemia drug that was suspended amid safety concerns nearly two months ago is being allowed back on the U.S. market, though restricted to a smaller group of patients.
****